Powering trials across leading research organizations

Lilly
Sanofi
AstraZeneca
Biogen
Zurabio
Olema Oncology

Clincove powers immunology and inflammation clinical trials with integrated biomarker dashboards, mobile-first patient-reported outcome collection, competitive enrollment intelligence, and global regulatory submission support for biologic and biosimilar pathways.

Common Challenges

Challenges in Immunology Trials

These are the problems that slow down immunology research. Clincove was designed to solve them.

Biomarker-Driven Designs

Modern immunology trials depend on biomarker stratification and response-adaptive designs. Patients must be assigned to treatment arms based on real-time biomarker profiles, requiring tight integration between labs and the EDC.

Patient-Reported Outcomes

Capturing PROs consistently across sites, languages, and devices is critical for endpoint assessment in conditions like RA, IBD, and psoriasis. Low completion rates or inconsistent capture windows can compromise primary endpoints.

Competitive Enrollment

Immunology indications like RA, IBD, and psoriasis have dozens of overlapping competitive trials at any given time. Sites struggle to meet enrollment targets when patients are being recruited into competing studies simultaneously.

Global Regulatory Variations

Different markets have different biosimilar and biologic approval pathways. FDA, EMA, and PMDA each require distinct documentation packages, and keeping track of pathway-specific requirements across regions adds significant complexity.

The Clincove Advantage

How Clincove Solves It

Purpose-built features that address the specific needs of immunology clinical trials.

Biomarker Dashboard

Centralized view of biomarker data across sites with automated stratification and cohort tracking. Lab results feed directly into treatment assignment logic, ensuring patients are allocated correctly based on their biomarker profile.

ePRO Integration

Mobile-first PRO capture with multilingual support, configurable reminders, and real-time compliance monitoring. Patients complete assessments on their own devices with automated window tracking and escalation for missed entries.

Competitive Intelligence

Site-level enrollment tracking with competitive landscape awareness to optimize recruitment strategy. Clincove identifies sites at risk of underperformance and recommends reallocation before enrollment gaps become critical.

Global Submission Support

Pre-built regulatory packages for FDA, EMA, and PMDA biosimilar and biologic pathways. Clincove generates region-specific submission documents and tracks pathway milestones across all active regulatory filings.

Results That Matter

Measurable impact for immunology trial teams using Clincove.

45%
Faster biomarker analysis
92%
PRO completion rate
30%
Enrollment acceleration

Related Therapeutic Areas

Explore how Clincove supports trials across other therapeutic areas.

Frequently Asked Questions

Common questions about immunology clinical trial software.

Clincove integrates directly with central and local labs to receive biomarker results in real time. These results feed into automated stratification logic that assigns patients to the correct treatment arm based on their biomarker profile, with full audit trails for every assignment decision.

Clincove provides mobile-first electronic patient-reported outcomes with multilingual support, configurable assessment windows, automated reminders, and real-time compliance dashboards. The platform supports validated instruments for conditions like RA, IBD, psoriasis, and lupus.

Clincove provides site-level enrollment dashboards with competitive landscape intelligence. The platform tracks enrollment velocity against targets, identifies underperforming sites early, and recommends patient reallocation strategies to keep trials on track despite competitive pressure.

Have Questions?

Have questions about Clincove? We're here to help you find the right solution for your clinical trial needs.

Personalized platform walkthrough
Discuss your specific trial needs
No commitment required
FDA 21 CFR Part 11
HIPAA & GDPR compliant
You're subscribed!